Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.74814966 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.74814966 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.74814966 |
4 | modulation by symbiont of host immune response (GO:0052553) | 6.74814966 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.74814966 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.74814966 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.20082782 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.63619695 |
9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.45135370 |
10 | macrophage activation involved in immune response (GO:0002281) | 4.89213558 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.86476592 |
12 | regulation of interferon-alpha production (GO:0032647) | 4.59200031 |
13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.59052799 |
14 | immunoglobulin mediated immune response (GO:0016064) | 4.50362125 |
15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.45135086 |
16 | response to host immune response (GO:0052572) | 4.45135086 |
17 | response to peptidoglycan (GO:0032494) | 4.24383922 |
18 | respiratory burst (GO:0045730) | 4.03367903 |
19 | microglial cell activation (GO:0001774) | 3.98142006 |
20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95829077 |
21 | response to host (GO:0075136) | 3.95829077 |
22 | response to host defenses (GO:0052200) | 3.95829077 |
23 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.79051712 |
24 | natural killer cell mediated immunity (GO:0002228) | 3.79051712 |
25 | granulocyte activation (GO:0036230) | 3.75591922 |
26 | neutrophil activation (GO:0042119) | 3.72313943 |
27 | myeloid cell activation involved in immune response (GO:0002275) | 3.71566858 |
28 | actin-myosin filament sliding (GO:0033275) | 3.69349299 |
29 | muscle filament sliding (GO:0030049) | 3.69349299 |
30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62493675 |
31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61923247 |
32 | macrophage activation (GO:0042116) | 3.50847938 |
33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49990768 |
34 | skeletal muscle contraction (GO:0003009) | 3.47679257 |
35 | positive regulation of interferon-beta production (GO:0032728) | 3.46761533 |
36 | pinocytosis (GO:0006907) | 3.43590428 |
37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.42083343 |
38 | detection of molecule of bacterial origin (GO:0032490) | 3.41165131 |
39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.37788162 |
40 | B cell mediated immunity (GO:0019724) | 3.36888838 |
41 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.36753125 |
42 | positive regulation of mast cell activation (GO:0033005) | 3.35234383 |
43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31844716 |
44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31844716 |
45 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.31599633 |
46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31255139 |
47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30647447 |
48 | regulation of mononuclear cell migration (GO:0071675) | 3.28696606 |
49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27184268 |
50 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.27002870 |
51 | barbed-end actin filament capping (GO:0051016) | 3.23872046 |
52 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.23241862 |
53 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.22840980 |
54 | negative regulation of cell killing (GO:0031342) | 3.21394452 |
55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.21394452 |
56 | I-kappaB phosphorylation (GO:0007252) | 3.19906820 |
57 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.17547935 |
58 | response to muramyl dipeptide (GO:0032495) | 3.16254683 |
59 | protein localization to endosome (GO:0036010) | 3.15049028 |
60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14823752 |
61 | negative regulation of interleukin-12 production (GO:0032695) | 3.11869467 |
62 | regulation of mast cell degranulation (GO:0043304) | 3.06723930 |
63 | superoxide anion generation (GO:0042554) | 3.05972909 |
64 | T-helper 1 type immune response (GO:0042088) | 3.05963832 |
65 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.02404834 |
66 | regulation of antigen processing and presentation (GO:0002577) | 3.01710749 |
67 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.00982636 |
68 | detection of other organism (GO:0098543) | 3.00310447 |
69 | reactive oxygen species biosynthetic process (GO:1903409) | 3.00247128 |
70 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.99753259 |
71 | actin-mediated cell contraction (GO:0070252) | 2.99236826 |
72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.98445913 |
73 | positive regulation of mast cell degranulation (GO:0043306) | 2.98445913 |
74 | leukocyte mediated cytotoxicity (GO:0001909) | 2.98437263 |
75 | germinal center formation (GO:0002467) | 2.97708228 |
76 | cellular extravasation (GO:0045123) | 2.97470775 |
77 | regulation of mast cell activation (GO:0033003) | 2.96152697 |
78 | negative regulation of interleukin-17 production (GO:0032700) | 2.96083860 |
79 | regulation of skeletal muscle contraction (GO:0014819) | 2.95077007 |
80 | neutrophil mediated immunity (GO:0002446) | 2.91892094 |
81 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.90868889 |
82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89759481 |
83 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89123773 |
84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88850882 |
85 | negative regulation of mast cell activation (GO:0033004) | 2.87059267 |
86 | positive regulation of B cell differentiation (GO:0045579) | 2.86546402 |
87 | skeletal muscle adaptation (GO:0043501) | 2.85466631 |
88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84761500 |
89 | type I interferon signaling pathway (GO:0060337) | 2.84473782 |
90 | cellular response to type I interferon (GO:0071357) | 2.84473782 |
91 | response to type I interferon (GO:0034340) | 2.83133112 |
92 | regulation of cholesterol storage (GO:0010885) | 2.82296337 |
93 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.82077988 |
94 | positive regulation of receptor recycling (GO:0001921) | 2.81943897 |
95 | positive regulation of leukocyte degranulation (GO:0043302) | 2.81409696 |
96 | mannose metabolic process (GO:0006013) | 2.80933848 |
97 | myeloid leukocyte activation (GO:0002274) | 2.79834127 |
98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.78638643 |
99 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.76197820 |
100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75941167 |
101 | regulation of necroptotic process (GO:0060544) | 2.75066874 |
102 | detection of bacterium (GO:0016045) | 2.74382534 |
103 | monocyte chemotaxis (GO:0002548) | 2.74226216 |
104 | response to interferon-alpha (GO:0035455) | 2.73446266 |
105 | detection of external biotic stimulus (GO:0098581) | 2.73268173 |
106 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.71280054 |
107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69609503 |
108 | stress fiber assembly (GO:0043149) | 2.68616890 |
109 | negative regulation of necroptotic process (GO:0060546) | 2.67838641 |
110 | lymphocyte mediated immunity (GO:0002449) | 2.66811673 |
111 | lymphocyte chemotaxis (GO:0048247) | 2.65951984 |
112 | regulation of leukocyte degranulation (GO:0043300) | 2.65341433 |
113 | response to thyroid hormone (GO:0097066) | 2.63501832 |
114 | cellular response to interferon-beta (GO:0035458) | 2.63460421 |
115 | actin filament-based movement (GO:0030048) | 2.62414055 |
116 | myeloid dendritic cell activation (GO:0001773) | 2.61346676 |
117 | myeloid dendritic cell differentiation (GO:0043011) | 2.60400243 |
118 | cytidine deamination (GO:0009972) | 2.59974037 |
119 | cytidine metabolic process (GO:0046087) | 2.59974037 |
120 | cytidine catabolic process (GO:0006216) | 2.59974037 |
121 | defense response to protozoan (GO:0042832) | 2.59173079 |
122 | response to laminar fluid shear stress (GO:0034616) | 2.57694223 |
123 | leukocyte aggregation (GO:0070486) | 2.57606560 |
124 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.57130948 |
125 | glycosphingolipid catabolic process (GO:0046479) | 2.55145655 |
126 | response to interferon-beta (GO:0035456) | 2.54829532 |
127 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47817410 |
128 | positive regulation of myotube differentiation (GO:0010831) | 2.46222778 |
129 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.42658223 |
130 | regulation of macrophage cytokine production (GO:0010935) | 2.41857248 |
131 | Golgi transport vesicle coating (GO:0048200) | 2.41661008 |
132 | COPI coating of Golgi vesicle (GO:0048205) | 2.41661008 |
133 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.41425956 |
134 | hypotonic response (GO:0006971) | 2.40149435 |
135 | regulation of necrotic cell death (GO:0010939) | 2.39466022 |
136 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34638198 |
137 | detection of biotic stimulus (GO:0009595) | 2.34347973 |
138 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.34058925 |
139 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32307850 |
140 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.30768570 |
141 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.27684879 |
142 | cell-substrate junction assembly (GO:0007044) | 2.26254121 |
143 | cell adhesion mediated by integrin (GO:0033627) | 2.24988570 |
144 | glycolipid catabolic process (GO:0019377) | 2.23701159 |
145 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.23602333 |
146 | negative regulation of cell size (GO:0045792) | 2.21556777 |
147 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.21551298 |
148 | hyaluronan catabolic process (GO:0030214) | 2.20928920 |
149 | sarcomere organization (GO:0045214) | 2.20031294 |
150 | apoptotic cell clearance (GO:0043277) | 2.17720653 |
151 | modulation by symbiont of host cellular process (GO:0044068) | 2.17419103 |
152 | peptide catabolic process (GO:0043171) | 2.17409560 |
153 | NIK/NF-kappaB signaling (GO:0038061) | 2.16970074 |
154 | regulation of platelet aggregation (GO:0090330) | 2.16774048 |
155 | pentose-phosphate shunt (GO:0006098) | 2.15803560 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.24012615 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.06459977 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.02291761 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.13009269 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.97899104 |
6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58922352 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.55155618 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.39255171 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25711991 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19188999 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12943220 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02478117 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68756542 |
14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.59715493 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56098294 |
16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35676588 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35332795 |
18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29951263 |
19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.29488636 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21537424 |
21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.20377624 |
22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14161776 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09331941 |
24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07248421 |
25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01162037 |
26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.99064325 |
27 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93142543 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89383179 |
29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88934092 |
30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88557197 |
31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.87012677 |
32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85023314 |
33 | MYC_22102868_ChIP-Seq_BL_Human | 1.84847188 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84248985 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79380168 |
36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.77578068 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75766363 |
38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75718132 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75696592 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73943406 |
41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69954671 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69494645 |
43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63956367 |
44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.63830056 |
45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61639225 |
46 | MAF_26560356_Chip-Seq_TH1_Human | 1.59138237 |
47 | MYB_26560356_Chip-Seq_TH2_Human | 1.58381045 |
48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55336254 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51579851 |
50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50553636 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50537330 |
52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.48921575 |
53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48033875 |
54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43489212 |
55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43279824 |
56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42978683 |
57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41920344 |
58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41282361 |
59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40898907 |
60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40157916 |
61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38571526 |
62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35679158 |
63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35328277 |
64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34848120 |
65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34621415 |
66 | MYB_26560356_Chip-Seq_TH1_Human | 1.33942296 |
67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31859922 |
68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31501774 |
69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30151333 |
70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28016412 |
71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27937901 |
72 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27829542 |
73 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27829542 |
74 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27780666 |
75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27672487 |
76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25835433 |
77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24137476 |
78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23777383 |
79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23298047 |
80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21823602 |
81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21524429 |
82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21129919 |
83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19845906 |
84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19352520 |
85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16753567 |
86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16445852 |
87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15674244 |
88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14741017 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14392128 |
90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13113303 |
91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12796816 |
92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10509260 |
93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10251390 |
94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09627858 |
95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09595714 |
96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08848828 |
97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07688428 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07348576 |
99 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07122017 |
100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05217949 |
101 | * P68_20966046_ChIP-Seq_HELA_Human | 1.04224564 |
102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04067012 |
103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.03974635 |
104 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.03821953 |
105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03694261 |
106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03528508 |
107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03350832 |
108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02012721 |
109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02002762 |
110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01366344 |
111 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01024744 |
112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00050902 |
113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99631636 |
114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94335072 |
115 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94183517 |
116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92916091 |
117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92493785 |
118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92493785 |
119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92250900 |
120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91492934 |
121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91222225 |
122 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.88042778 |
123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87925005 |
124 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87251368 |
125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87237250 |
126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84701950 |
127 | MAF_26560356_Chip-Seq_TH2_Human | 0.84442916 |
128 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81497439 |
129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80533301 |
130 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80479829 |
131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79554494 |
132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79554494 |
133 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.79419570 |
134 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78710973 |
135 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78475648 |
136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77635547 |
137 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77472269 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.14825601 |
2 | MP0005451_abnormal_body_composition | 3.79461010 |
3 | MP0005058_abnormal_lysosome_morphology | 3.74246363 |
4 | MP0003436_decreased_susceptibility_to | 3.70425793 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.99632729 |
6 | MP0002419_abnormal_innate_immunity | 2.93836377 |
7 | MP0009785_altered_susceptibility_to | 2.91952414 |
8 | MP0005000_abnormal_immune_tolerance | 2.77256203 |
9 | MP0006082_CNS_inflammation | 2.73801476 |
10 | MP0003724_increased_susceptibility_to | 2.72929360 |
11 | MP0000751_myopathy | 2.64102194 |
12 | MP0003303_peritoneal_inflammation | 2.62942067 |
13 | MP0005025_abnormal_response_to | 2.56387788 |
14 | MP0001790_abnormal_immune_system | 2.39608098 |
15 | MP0005387_immune_system_phenotype | 2.39608098 |
16 | MP0002452_abnormal_antigen_presenting | 2.36321375 |
17 | MP0000685_abnormal_immune_system | 2.33347922 |
18 | MP0003172_abnormal_lysosome_physiology | 2.23935893 |
19 | MP0001800_abnormal_humoral_immune | 2.21351981 |
20 | MP0002723_abnormal_immune_serum | 2.14929075 |
21 | MP0005671_abnormal_response_to | 2.10288442 |
22 | MP0001533_abnormal_skeleton_physiology | 2.08314279 |
23 | MP0004510_myositis | 2.06756642 |
24 | MP0005464_abnormal_platelet_physiology | 2.03762507 |
25 | MP0009840_abnormal_foam_cell | 1.99064591 |
26 | MP0001819_abnormal_immune_cell | 1.96201320 |
27 | MP0002420_abnormal_adaptive_immunity | 1.94368053 |
28 | MP0000343_altered_response_to | 1.87010107 |
29 | MP0001853_heart_inflammation | 1.83328266 |
30 | MP0004036_abnormal_muscle_relaxation | 1.81074516 |
31 | MP0000747_muscle_weakness | 1.81023470 |
32 | MP0002166_altered_tumor_susceptibility | 1.78454165 |
33 | MP0002405_respiratory_system_inflammati | 1.75549365 |
34 | MP0003191_abnormal_cellular_cholesterol | 1.69222369 |
35 | MP0003448_altered_tumor_morphology | 1.66987203 |
36 | MP0004233_abnormal_muscle_weight | 1.65841639 |
37 | MP0000759_abnormal_skeletal_muscle | 1.65401845 |
38 | MP0001845_abnormal_inflammatory_respons | 1.64843123 |
39 | MP0000569_abnormal_digit_pigmentation | 1.63574736 |
40 | MP0008260_abnormal_autophagy | 1.63436254 |
41 | MP0002006_tumorigenesis | 1.60014079 |
42 | MP0004947_skin_inflammation | 1.58395413 |
43 | MP0003828_pulmonary_edema | 1.58164824 |
44 | MP0009764_decreased_sensitivity_to | 1.57612425 |
45 | MP0008469_abnormal_protein_level | 1.51731172 |
46 | MP0004087_abnormal_muscle_fiber | 1.51629439 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.50938983 |
48 | MP0003091_abnormal_cell_migration | 1.47353837 |
49 | MP0003300_gastrointestinal_ulcer | 1.40532186 |
50 | MP0009278_abnormal_bone_marrow | 1.40017409 |
51 | MP0001849_ear_inflammation | 1.39529574 |
52 | MP0010155_abnormal_intestine_physiology | 1.38894384 |
53 | MP0000716_abnormal_immune_system | 1.38873192 |
54 | MP0002998_abnormal_bone_remodeling | 1.38685541 |
55 | MP0001545_abnormal_hematopoietic_system | 1.38061337 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.38061337 |
57 | MP0004145_abnormal_muscle_electrophysio | 1.37472557 |
58 | MP0003075_altered_response_to | 1.36687084 |
59 | MP0004084_abnormal_cardiac_muscle | 1.36659344 |
60 | MP0005310_abnormal_salivary_gland | 1.35965729 |
61 | MP0005330_cardiomyopathy | 1.32354322 |
62 | MP0000858_altered_metastatic_potential | 1.30040968 |
63 | MP0002398_abnormal_bone_marrow | 1.28734534 |
64 | MP0000749_muscle_degeneration | 1.27141845 |
65 | MP0000689_abnormal_spleen_morphology | 1.25108384 |
66 | MP0005167_abnormal_blood-brain_barrier | 1.22677764 |
67 | MP0000604_amyloidosis | 1.21525723 |
68 | MP0003453_abnormal_keratinocyte_physiol | 1.20781632 |
69 | MP0003690_abnormal_glial_cell | 1.18521068 |
70 | MP0002429_abnormal_blood_cell | 1.16720192 |
71 | MP0005166_decreased_susceptibility_to | 1.16254817 |
72 | MP0009333_abnormal_splenocyte_physiolog | 1.15604763 |
73 | MP0005174_abnormal_tail_pigmentation | 1.15447308 |
74 | MP0003186_abnormal_redox_activity | 1.14905215 |
75 | MP0010307_abnormal_tumor_latency | 1.14421815 |
76 | MP0003566_abnormal_cell_adhesion | 1.13263309 |
77 | MP0002269_muscular_atrophy | 1.12669580 |
78 | MP0002722_abnormal_immune_system | 1.10229578 |
79 | MP0005023_abnormal_wound_healing | 1.08793423 |
80 | MP0002933_joint_inflammation | 1.05838555 |
81 | MP0004130_abnormal_muscle_cell | 1.05657785 |
82 | MP0005369_muscle_phenotype | 1.02190979 |
83 | MP0005390_skeleton_phenotype | 1.00745649 |
84 | MP0002254_reproductive_system_inflammat | 0.99356982 |
85 | MP0001542_abnormal_bone_strength | 0.98516374 |
86 | MP0005257_abnormal_intraocular_pressure | 0.98380215 |
87 | MP0005165_increased_susceptibility_to | 0.98380140 |
88 | MP0008438_abnormal_cutaneous_collagen | 0.98242161 |
89 | MP0003646_muscle_fatigue | 0.96506195 |
90 | MP0000249_abnormal_blood_vessel | 0.96326566 |
91 | MP0000465_gastrointestinal_hemorrhage | 0.96071982 |
92 | MP0002972_abnormal_cardiac_muscle | 0.95283893 |
93 | MP0004272_abnormal_basement_membrane | 0.93922581 |
94 | MP0005620_abnormal_muscle_contractility | 0.92809851 |
95 | MP0001851_eye_inflammation | 0.91366388 |
96 | MP0005164_abnormal_response_to | 0.90730588 |
97 | MP0006138_congestive_heart_failure | 0.90569757 |
98 | MP0004858_abnormal_nervous_system | 0.90371515 |
99 | MP0002138_abnormal_hepatobiliary_system | 0.90078584 |
100 | MP0000750_abnormal_muscle_regeneration | 0.89048319 |
101 | MP0009763_increased_sensitivity_to | 0.88745431 |
102 | MP0004782_abnormal_surfactant_physiolog | 0.88065014 |
103 | MP0005666_abnormal_adipose_tissue | 0.85895904 |
104 | MP0010630_abnormal_cardiac_muscle | 0.83786238 |
105 | MP0003183_abnormal_peptide_metabolism | 0.81829052 |
106 | MP0005375_adipose_tissue_phenotype | 0.81184292 |
107 | MP0003705_abnormal_hypodermis_morpholog | 0.80978422 |
108 | MP0001873_stomach_inflammation | 0.80303405 |
109 | MP0002009_preneoplasia | 0.79933692 |
110 | MP0000767_abnormal_smooth_muscle | 0.79643046 |
111 | MP0003763_abnormal_thymus_physiology | 0.79414661 |
112 | MP0003045_fibrosis | 0.79358069 |
113 | MP0008004_abnormal_stomach_pH | 0.79330919 |
114 | MP0002332_abnormal_exercise_endurance | 0.78956814 |
115 | MP0004883_abnormal_blood_vessel | 0.78450979 |
116 | MP0003195_calcinosis | 0.77164646 |
117 | MP0002277_abnormal_respiratory_mucosa | 0.77059555 |
118 | MP0002877_abnormal_melanocyte_morpholog | 0.76684037 |
119 | MP0003795_abnormal_bone_structure | 0.75086396 |
120 | MP0002106_abnormal_muscle_physiology | 0.74974288 |
121 | MP0002396_abnormal_hematopoietic_system | 0.73468134 |
122 | MP0004185_abnormal_adipocyte_glucose | 0.71095650 |
123 | MP0001958_emphysema | 0.71061933 |
124 | MP0000733_abnormal_muscle_development | 0.69038714 |
125 | MP0003950_abnormal_plasma_membrane | 0.68837376 |
126 | MP0002136_abnormal_kidney_physiology | 0.68377780 |
127 | MP0005076_abnormal_cell_differentiation | 0.68305254 |
128 | MP0006054_spinal_hemorrhage | 0.68277083 |
129 | MP0000371_diluted_coat_color | 0.67255235 |
130 | MP0000490_abnormal_crypts_of | 0.66722862 |
131 | MP0003279_aneurysm | 0.66309386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.68442266 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.84565795 |
3 | Eczematoid dermatitis (HP:0000976) | 5.52555666 |
4 | Increased cerebral lipofuscin (HP:0011813) | 5.24060329 |
5 | Vacuolated lymphocytes (HP:0001922) | 5.19631498 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.04687256 |
7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.72384914 |
8 | Abnormality of macrophages (HP:0004311) | 4.70715549 |
9 | Autoimmune thrombocytopenia (HP:0001973) | 4.38597239 |
10 | Systemic lupus erythematosus (HP:0002725) | 4.05842116 |
11 | Axonal loss (HP:0003447) | 3.96090376 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77579051 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77579051 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77579051 |
15 | Distal lower limb muscle weakness (HP:0009053) | 3.65681922 |
16 | Myositis (HP:0100614) | 3.54691414 |
17 | Recurrent skin infections (HP:0001581) | 3.52899633 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 3.52499841 |
19 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.51832885 |
20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.50776412 |
21 | Disinhibition (HP:0000734) | 3.48464503 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36399759 |
23 | Dysostosis multiplex (HP:0000943) | 3.32517294 |
24 | Gingivitis (HP:0000230) | 3.32025181 |
25 | Exercise-induced muscle cramps (HP:0003710) | 3.29464010 |
26 | Obstructive lung disease (HP:0006536) | 3.27926440 |
27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27926440 |
28 | Increased variability in muscle fiber diameter (HP:0003557) | 3.24715458 |
29 | Orchitis (HP:0100796) | 3.19922685 |
30 | Round ear (HP:0100830) | 3.09321792 |
31 | Recurrent fungal infections (HP:0002841) | 3.04352419 |
32 | Muscle fiber splitting (HP:0003555) | 3.02498178 |
33 | Distal lower limb amyotrophy (HP:0008944) | 3.01817800 |
34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01443121 |
35 | Hyporeflexia of lower limbs (HP:0002600) | 2.93852241 |
36 | EMG: myopathic abnormalities (HP:0003458) | 2.90444166 |
37 | Muscle fiber inclusion bodies (HP:0100299) | 2.89445333 |
38 | Protrusio acetabuli (HP:0003179) | 2.88878679 |
39 | Pustule (HP:0200039) | 2.86546842 |
40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81454790 |
41 | Mucopolysacchariduria (HP:0008155) | 2.81454790 |
42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.78688273 |
43 | Recurrent viral infections (HP:0004429) | 2.78105747 |
44 | Retrobulbar optic neuritis (HP:0100654) | 2.76488500 |
45 | Optic neuritis (HP:0100653) | 2.76488500 |
46 | Premature rupture of membranes (HP:0001788) | 2.75325395 |
47 | Loss of speech (HP:0002371) | 2.75322148 |
48 | Glomerulonephritis (HP:0000099) | 2.74212870 |
49 | Myocardial infarction (HP:0001658) | 2.72344939 |
50 | Ulnar deviation of the wrist (HP:0003049) | 2.71546586 |
51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.69252859 |
52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.69252859 |
53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.69252859 |
54 | Basal ganglia calcification (HP:0002135) | 2.69017131 |
55 | Urticaria (HP:0001025) | 2.67487006 |
56 | Petechiae (HP:0000967) | 2.67443427 |
57 | Rhabdomyolysis (HP:0003201) | 2.65963637 |
58 | Nemaline bodies (HP:0003798) | 2.65787356 |
59 | Stomatitis (HP:0010280) | 2.65013078 |
60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.59495956 |
61 | Thick nail (HP:0001805) | 2.59176528 |
62 | Cellulitis (HP:0100658) | 2.58592896 |
63 | Osteolytic defects of the hand bones (HP:0009699) | 2.57397070 |
64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57397070 |
65 | Periodontitis (HP:0000704) | 2.54547982 |
66 | Spinal rigidity (HP:0003306) | 2.52240090 |
67 | Neck muscle weakness (HP:0000467) | 2.51507605 |
68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.49799209 |
69 | Interstitial pulmonary disease (HP:0006530) | 2.48634031 |
70 | Frequent falls (HP:0002359) | 2.48567427 |
71 | Bulbar palsy (HP:0001283) | 2.46517633 |
72 | Vasculitis (HP:0002633) | 2.45946943 |
73 | Asymmetric septal hypertrophy (HP:0001670) | 2.44138614 |
74 | Difficulty running (HP:0009046) | 2.43434203 |
75 | Agnosia (HP:0010524) | 2.42429884 |
76 | Tetraparesis (HP:0002273) | 2.41883455 |
77 | Prostate neoplasm (HP:0100787) | 2.38933685 |
78 | Osteomyelitis (HP:0002754) | 2.33735946 |
79 | Distal arthrogryposis (HP:0005684) | 2.32075304 |
80 | Nausea (HP:0002018) | 2.31915012 |
81 | Hepatosplenomegaly (HP:0001433) | 2.31359351 |
82 | Vertebral compression fractures (HP:0002953) | 2.31012877 |
83 | Slender build (HP:0001533) | 2.30240095 |
84 | Hematochezia (HP:0002573) | 2.29490873 |
85 | Difficulty climbing stairs (HP:0003551) | 2.24262271 |
86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23181185 |
87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23181185 |
88 | Cerebral aneurysm (HP:0004944) | 2.22400963 |
89 | Nephritis (HP:0000123) | 2.18998341 |
90 | Pathologic fracture (HP:0002756) | 2.18777134 |
91 | Recurrent pneumonia (HP:0006532) | 2.16812140 |
92 | Myoglobinuria (HP:0002913) | 2.16068997 |
93 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.15489632 |
94 | Aortic aneurysm (HP:0004942) | 2.10779285 |
95 | Pulmonary infiltrates (HP:0002113) | 2.08351935 |
96 | Abnormality of the calf musculature (HP:0001430) | 2.07894121 |
97 | Achilles tendon contracture (HP:0001771) | 2.07737665 |
98 | Muscle stiffness (HP:0003552) | 2.07710382 |
99 | Meningitis (HP:0001287) | 2.05727154 |
100 | Spontaneous hematomas (HP:0007420) | 2.05376800 |
101 | Myopathic facies (HP:0002058) | 2.04657427 |
102 | Cervical subluxation (HP:0003308) | 2.04081925 |
103 | Exercise-induced myalgia (HP:0003738) | 2.01970531 |
104 | Increased serum ferritin (HP:0003281) | 2.01441707 |
105 | Chronic otitis media (HP:0000389) | 2.01209216 |
106 | Gingival bleeding (HP:0000225) | 2.00970777 |
107 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00937924 |
108 | Colitis (HP:0002583) | 2.00685513 |
109 | Leukocytosis (HP:0001974) | 1.99419054 |
110 | Purpura (HP:0000979) | 1.98210779 |
111 | Type 1 muscle fiber predominance (HP:0003803) | 1.97408435 |
112 | Poor head control (HP:0002421) | 1.95446915 |
113 | Spondylolisthesis (HP:0003302) | 1.92851700 |
114 | Polycythemia (HP:0001901) | 1.92616666 |
115 | Lower limb amyotrophy (HP:0007210) | 1.92064112 |
116 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91101374 |
117 | Thin bony cortex (HP:0002753) | 1.91018863 |
118 | Bone pain (HP:0002653) | 1.90245059 |
119 | Joint stiffness (HP:0001387) | 1.89286485 |
120 | Fatigue (HP:0012378) | 1.89173072 |
121 | Increased connective tissue (HP:0009025) | 1.89125808 |
122 | Abnormality of the Achilles tendon (HP:0005109) | 1.87533847 |
123 | Peritonitis (HP:0002586) | 1.87269011 |
124 | Dilatation of the ascending aorta (HP:0005111) | 1.86162247 |
125 | Ventricular tachycardia (HP:0004756) | 1.85211623 |
126 | Calf muscle hypertrophy (HP:0008981) | 1.84478439 |
127 | Amyloidosis (HP:0011034) | 1.83379759 |
128 | Easy fatigability (HP:0003388) | 1.81233279 |
129 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.81215373 |
130 | Subaortic stenosis (HP:0001682) | 1.81215373 |
131 | Upper motor neuron abnormality (HP:0002127) | 1.79417959 |
132 | Joint hemorrhage (HP:0005261) | 1.79390802 |
133 | Inflammation of the large intestine (HP:0002037) | 1.78982348 |
134 | Epistaxis (HP:0000421) | 1.78553332 |
135 | Abnormality of complement system (HP:0005339) | 1.78504433 |
136 | Generalized amyotrophy (HP:0003700) | 1.78316779 |
137 | Vascular tortuosity (HP:0004948) | 1.78213389 |
138 | J-shaped sella turcica (HP:0002680) | 1.77518423 |
139 | Keratoconjunctivitis sicca (HP:0001097) | 1.77051655 |
140 | Arterial thrombosis (HP:0004420) | 1.76928138 |
141 | Abnormality of the lumbar spine (HP:0100712) | 1.75568069 |
142 | Abnormality of iron homeostasis (HP:0011031) | 1.74600886 |
143 | Progressive visual loss (HP:0000529) | 1.74562047 |
144 | Bone cyst (HP:0012062) | 1.73715460 |
145 | Arterial tortuosity (HP:0005116) | 1.72036056 |
146 | Scapular winging (HP:0003691) | 1.71948549 |
147 | Aneurysm (HP:0002617) | 1.71848920 |
148 | Malignant hyperthermia (HP:0002047) | 1.70642096 |
149 | Aortic dissection (HP:0002647) | 1.69759989 |
150 | Prolonged bleeding time (HP:0003010) | 1.68378298 |
151 | Chest pain (HP:0100749) | 1.65215530 |
152 | Generalized muscle weakness (HP:0003324) | 1.65080297 |
153 | Fragile skin (HP:0001030) | 1.64944997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 3.74828891 |
2 | MAP3K14 | 3.43663867 |
3 | TBK1 | 3.15565714 |
4 | TYK2 | 3.12657281 |
5 | KIT | 3.08611105 |
6 | RIPK4 | 2.74428358 |
7 | IRAK3 | 2.61953227 |
8 | TTN | 2.60918193 |
9 | IRAK4 | 2.59409558 |
10 | PRPF4B | 2.52913311 |
11 | MAP4K1 | 2.48255311 |
12 | PBK | 2.48019023 |
13 | IKBKE | 2.37555036 |
14 | NME2 | 2.37398258 |
15 | ERN1 | 2.34139677 |
16 | MAP2K3 | 2.17536576 |
17 | JAK3 | 2.08176523 |
18 | NEK9 | 2.07247133 |
19 | SIK1 | 2.04489676 |
20 | IKBKB | 2.03582505 |
21 | TGFBR2 | 1.78999859 |
22 | JAK1 | 1.68356092 |
23 | PIM2 | 1.67582454 |
24 | TRPM7 | 1.65701615 |
25 | OBSCN | 1.51066356 |
26 | TXK | 1.42581574 |
27 | ZAP70 | 1.36230570 |
28 | TEC | 1.35606393 |
29 | TAOK3 | 1.30661104 |
30 | TRIB3 | 1.30085947 |
31 | MAP3K3 | 1.29736757 |
32 | CSF1R | 1.28812695 |
33 | SYK | 1.27703955 |
34 | PIK3CG | 1.22250578 |
35 | CSK | 1.21937090 |
36 | BTK | 1.16301698 |
37 | HCK | 1.14661978 |
38 | TESK1 | 1.14566528 |
39 | SMG1 | 1.12423352 |
40 | ICK | 1.09965491 |
41 | MAP3K11 | 1.09239421 |
42 | STK10 | 1.07098987 |
43 | RIPK1 | 1.07053757 |
44 | TIE1 | 1.06757852 |
45 | KSR2 | 1.04569100 |
46 | RPS6KA4 | 1.04319489 |
47 | CHUK | 1.03799915 |
48 | JAK2 | 1.03223587 |
49 | TESK2 | 1.02064099 |
50 | LYN | 1.01853757 |
51 | PIM1 | 1.01650891 |
52 | LCK | 1.01563031 |
53 | ZAK | 1.00844974 |
54 | MATK | 1.00150487 |
55 | MUSK | 0.99721032 |
56 | EEF2K | 0.99225439 |
57 | MST4 | 0.98973662 |
58 | MAP3K13 | 0.98232752 |
59 | CDC42BPA | 0.97404030 |
60 | BMX | 0.95948200 |
61 | PDPK1 | 0.94865578 |
62 | MAP3K7 | 0.94475811 |
63 | ABL2 | 0.93142788 |
64 | PRKD2 | 0.92994426 |
65 | ARAF | 0.92900399 |
66 | LRRK2 | 0.91376652 |
67 | PDGFRA | 0.90146787 |
68 | DDR2 | 0.88879981 |
69 | CAMK1D | 0.88236649 |
70 | PKN2 | 0.84645582 |
71 | MAPKAPK3 | 0.83360647 |
72 | GRK6 | 0.83085362 |
73 | GRK7 | 0.82232478 |
74 | TNK2 | 0.81864538 |
75 | STK4 | 0.81549841 |
76 | EPHB1 | 0.80291576 |
77 | ERBB3 | 0.78937210 |
78 | IRAK2 | 0.76554102 |
79 | MARK2 | 0.75992651 |
80 | EPHA2 | 0.74895999 |
81 | MAP3K6 | 0.74656640 |
82 | LIMK1 | 0.73228310 |
83 | MAPK7 | 0.72022109 |
84 | SIK3 | 0.71482092 |
85 | RPS6KA2 | 0.70528180 |
86 | CDK6 | 0.68299771 |
87 | PTK6 | 0.66996805 |
88 | FLT3 | 0.66505461 |
89 | DMPK | 0.65395677 |
90 | EGFR | 0.64061831 |
91 | ITK | 0.63540407 |
92 | FGR | 0.63119903 |
93 | FES | 0.61035794 |
94 | PRKCD | 0.60948606 |
95 | ABL1 | 0.60066227 |
96 | RPS6KC1 | 0.59352351 |
97 | RPS6KL1 | 0.59352351 |
98 | MARK3 | 0.58516615 |
99 | PDK1 | 0.58091453 |
100 | STK24 | 0.57511914 |
101 | DYRK1B | 0.56710349 |
102 | MAPK12 | 0.56438712 |
103 | MAP3K5 | 0.56119329 |
104 | PTK2 | 0.56098325 |
105 | KDR | 0.54381474 |
106 | PIK3CA | 0.53399471 |
107 | TAOK2 | 0.53130453 |
108 | FGFR3 | 0.52772076 |
109 | MST1R | 0.50874035 |
110 | CLK1 | 0.49505843 |
111 | PTK2B | 0.49059178 |
112 | MAP2K6 | 0.47658379 |
113 | MAPKAPK2 | 0.47342560 |
114 | NUAK1 | 0.46338239 |
115 | MAP3K10 | 0.45850859 |
116 | EPHA3 | 0.45517499 |
117 | ILK | 0.43911719 |
118 | EPHB2 | 0.42558708 |
119 | EIF2AK2 | 0.42494874 |
120 | MTOR | 0.42168660 |
121 | BMPR2 | 0.41182623 |
122 | PAK4 | 0.40977077 |
123 | PRKD1 | 0.39405961 |
124 | TAOK1 | 0.38729824 |
125 | MOS | 0.38630341 |
126 | MAPK4 | 0.38452317 |
127 | PRKAA2 | 0.38161165 |
128 | STK3 | 0.37656076 |
129 | FGFR4 | 0.37577303 |
130 | LMTK2 | 0.36967682 |
131 | MAP2K1 | 0.36490544 |
132 | PRKG2 | 0.33150873 |
133 | RPS6KA6 | 0.32983128 |
134 | MAP3K1 | 0.32793288 |
135 | PHKG2 | 0.30708117 |
136 | PHKG1 | 0.30708117 |
137 | PRKCQ | 0.30137926 |
138 | MYLK | 0.29930009 |
139 | SCYL2 | 0.28320272 |
140 | CDK9 | 0.27668067 |
141 | MAPK11 | 0.27020737 |
142 | CAMK1G | 0.26705592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.39432245 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24067200 |
3 | Lysosome_Homo sapiens_hsa04142 | 2.95706761 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73182429 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.54832886 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46097251 |
7 | Malaria_Homo sapiens_hsa05144 | 2.35703451 |
8 | Tuberculosis_Homo sapiens_hsa05152 | 2.34878947 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34308250 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.30984199 |
11 | Pertussis_Homo sapiens_hsa05133 | 2.25115473 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22853087 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.01940978 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00233720 |
15 | Phagosome_Homo sapiens_hsa04145 | 1.98312870 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97969750 |
17 | Measles_Homo sapiens_hsa05162 | 1.94169542 |
18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.91803552 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80259161 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.71457411 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70326021 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70177974 |
23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69187199 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68931430 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.61793345 |
26 | Apoptosis_Homo sapiens_hsa04210 | 1.60642404 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59262530 |
28 | Asthma_Homo sapiens_hsa05310 | 1.58475779 |
29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58359298 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56443489 |
31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54397453 |
32 | Salmonella infection_Homo sapiens_hsa05132 | 1.53915563 |
33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46941735 |
34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41455032 |
35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38319248 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30775783 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30178157 |
38 | Bladder cancer_Homo sapiens_hsa05219 | 1.29295119 |
39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.28633626 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26986971 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24063477 |
42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21659028 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17400338 |
44 | Shigellosis_Homo sapiens_hsa05131 | 1.13063280 |
45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.09718270 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 1.08131277 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07779225 |
48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03996063 |
49 | Amoebiasis_Homo sapiens_hsa05146 | 1.00778566 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00151484 |
51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99743482 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.95172636 |
53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92538003 |
54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92307293 |
55 | Platelet activation_Homo sapiens_hsa04611 | 0.90618278 |
56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90057557 |
57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89648276 |
58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89201417 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88106882 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87584743 |
61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85646165 |
62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84516174 |
63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81591898 |
64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81377262 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79987305 |
66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78876295 |
67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77857715 |
68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77447011 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77164604 |
70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76643710 |
71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72941345 |
72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71578398 |
73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69856692 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69253026 |
75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67825331 |
76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66141708 |
77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65165484 |
78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64751266 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62725220 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62321928 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61456337 |
82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60067384 |
83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59982514 |
84 | Glioma_Homo sapiens_hsa05214 | 0.59292911 |
85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59273751 |
86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58919497 |
87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57069500 |
88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55814300 |
89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55217130 |
90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54747745 |
91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54338945 |
92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54152356 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53315702 |
94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52671993 |
95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51835266 |
96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51811527 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51671584 |
98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51054771 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50296039 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48790755 |
101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48758642 |
102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46227093 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46150974 |
104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45726623 |
105 | Mineral absorption_Homo sapiens_hsa04978 | 0.44845804 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43739014 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.39898615 |
108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39890134 |
109 | Focal adhesion_Homo sapiens_hsa04510 | 0.37626835 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35087574 |
111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34509289 |
112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34232853 |
113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30959661 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30323907 |
115 | Endocytosis_Homo sapiens_hsa04144 | 0.29993889 |
116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28690893 |
117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26621757 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24051629 |
119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23453901 |
120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22918148 |
121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21633494 |
122 | ABC transporters_Homo sapiens_hsa02010 | 0.21569255 |
123 | Prion diseases_Homo sapiens_hsa05020 | 0.19240519 |